Post-approval studies (Phase 4)Study completedNCT00206102
What this trial is testing
The Cataractogenic Potential of Seroquel and Risperdal in the Treatment of Participants With Schizophrenia or Schizoaffective Disorder
Who this might be right for
SchizophreniaSchizoaffective Disorder
AstraZeneca 1,098